Abstract: The present disclosure relates to compositions, including foamable compositions with improved properties, such as those comprising waxes, emollients, foam adjuvants and/or active agents, and methods for preparing and using them.

Abstract: The present disclosure relates to novel topical formulations containing a tofacitinib and or a fingolimod that are useful for treating dermatological conditions, such as atopic dermatitis, psoriasis, vitiligo and eczema.

Abstract: The present disclosure relates to novel topical formulations containing a tofacitinib and or a fingolimod that are useful for treating dermatological conditions, such as atopic dermatitis, psoriasis, and eczema.

Abstract: A segmented subsystem, for use within an automated test platform, includes a first subsystem segment including a first data sequencer configured to coordinate the execution of one or more instructions within the first subsystem segment. A second subsystem segment includes a second data sequencer configured to coordinate the execution of one or more instructions within the second subsystem segment.

Abstract: A scalable test platform includes a PCIe-based event fabric. One or more instrument subsystems are coupled to the PCIe-based event fabric and configured to interface one or more devices under test and generate captured test data. One or more digital signal processing subsystems are coupled to the PCIe-based event fabric and configured to process the captured test data.

Abstract: A scalable test platform includes a PCIe-based event fabric. One or more CPU subsystems are coupled to the PCIe-based event fabric and configured to execute an automated test process. One or more instrument subsystems are coupled to the PCIe-based event fabric and configured to interface one or more devices under test.

Abstract: A method, computer program product, and computing system for, upon the occurrence of a computer-related event, comparing code utilized by one or more subsystems included within a scalable test platform to code available from a remote location. If the code available from the remote location is newer than the code utilized by one or more subsystems, the code available from the remote location is obtained, thus defining newer code. The code utilized by one or more subsystems is updated with the newer code.

Abstract: A segmented subsystem, for use within an automated test platform, includes a first subsystem segment configured to execute one or more instructions within the first subsystem segment. A second subsystem segment is configured to execute one or more instructions within the second subsystem segment. The first subsystem segment includes: a first functionality, a second functionality, and a status polling engine. The status polling engine is configured to: determine a first status for the first functionality and a second status for the second functionality, and generate a consolidated status indicator for the first subsystem segment based, at least in part, upon the first status for the first functionality and the second status for the second functionality.

Abstract: The present invention relates to non-aqueous emulsions stabilised by silica particles and to processes for making them. The invention further comprises: a particle stabilized oil-in-polar (o/polar o/p) emulsion comprising: a) a dispersed oil phase, b) a continuous polar phase substantially free of water, c) a particulate solid which is a silica particle dispersant possessing surface silanol groups (SiOH) sufficient to stabilize the emulsion, and where the emulsion is substantially free of emulsifiers, surfactants; and wherein the oil phase (a) is dispersed as discontinuous droplets in the polar phase (b); the silica particle dispersant (c) is absorbed on the surface of the oil phase (a); and the silica particle dispersant (c) is partially wetted by the polar phase (b).

Abstract: A scalable test platform includes a PCIe-based event fabric. One or more instrument subsystems are coupled to the PCIe-based event fabric and configured to interface one or more devices under test and generate captured test data.

Abstract: A method, computer program product, and computing system for, upon the occurrence of a computer-related event, comparing code utilized by one or more subsystems included within a scalable test platform to code available from a remote location. If the code available from the remote location is newer than the code utilized by one or more subsystems, the code available from the remote location is obtained, thus defining newer code. The code utilized by one or more subsystems is updated with the newer code.

Abstract: A segmented subsystem, for use within an automated test platform, includes a first subsystem segment configured to execute one or more instructions within the first subsystem segment. A second subsystem segment is configured to execute one or more instructions within the second subsystem segment. The first subsystem segment includes: a first functionality, a second functionality, and a status polling engine. The status polling engine is configured to: determine a first status for the first functionality and a second status for the second functionality, and generate a consolidated status indicator for the first subsystem segment based, at least in part, upon the first status for the first functionality and the second status for the second functionality.

Abstract: A scalable test platform includes a PCIe-based event fabric. One or more CPU subsystems are coupled to the PCIe-based event fabric and configured to execute an automated test process. One or more instrument subsystems are coupled to the PCIe-based event fabric and configured to interface one or more devices under test.

Abstract: A segmented subsystem, for use within an automated test platform, includes a first subsystem segment including a first data sequencer configured to coordinate the execution of one or more instructions within the first subsystem segment. A second subsystem segment includes a second data sequencer configured to coordinate the execution of one or more instructions within the second subsystem segment.

Abstract: A cosmetic composition is provided comprising (a) metal oxide particles; and (b) greater than 1.7% by weight of the cosmetic composition of cross-linked organopolysiloxane elastomer, wherein organo-functionalised silicone fibrils are bonded to and extend away from the surface of the metal oxide particles.

Abstract: A cosmetic foundation composition is provided having an SPF value of greater than or equal to 15, preferably greater than or equal to 18, more preferably greater than or equal to 20 and a ?LT value greater than or equal to 0.5, preferably greater than or equal to 1.0, more preferably greater than or equal to 2.5, where ?LT is measured according to the following equation: ?LT=?L2??L1 Where: ?L1=L1110?L115; ?L2=L2110?L215 L1 is a measurement of Ly taken on bare skin, to which no product has been applied; L2 is a measurement of Ly taken on skin, to which product has been applied; and Ly is the translucency value at a specific angle, y, from specular.

Abstract: A composition is provided comprising: (a) first metal oxide particles having a first number weighted average primary particle size from 1 nm to 50 nm; and (b) second metal oxide particles having a second number weighted average primary particle size which is greater than 50 nm and less than or equal to 200 nm; wherein organo-functionalised silicone fibrils are bonded to and extend away from the surface of one or both of the first and second metal oxide particles.

Abstract: A cosmetic composition is provided comprising: a) a cross-linked organopolysiloxane elastomer; b) a shine agent having the formula R—X—R? wherein R and R? are C6-C10 alkyl groups and X is an oxygen atom or a carbonate group.

Abstract: A cosmetic foundation composition is provided comprising greater than or equal to 6% by weight of the cosmetic foundation composition of metal oxide particles and having a ?LT value greater than or equal to 0.5, preferably greater than or equal to 1.5, more preferably greater than or equal to 2.5, where ?LT is measured according to the following equation: ?LT=?L2??L1 Where: ?L1=L1110?L115; ?L2=L2110?L215 L1 is a measurement of Ly taken on bare skin, to which no product has been applied; L2 is a measurement of Ly taken on skin, to which product has been applied; and Ly is the luminosity value at a specific angle, y, from specular.

Abstract: A cosmetic foundation composition is provided having a ?LT value greater than or equal to 3.5, preferably greater than or equal to 4.5, more preferably greater than or equal to 5.0, where ?LT is measured according to the following equation: ?LT=?L2??L1 Where: ?L1=L1110?L115; ?L2=L2110?L215 L1 is a measurement of Ly taken on bare skin, to which no product has been applied; L2 is a measurement of Ly taken on skin, to which product has been applied; and Ly is the luminosity value at a specific angle, y, from specular.